SciPhy
Nanotechnology Alternative & Traditional Medicine Natural Medicines & Medicinal Plants Pharmacology & Pharmacy Bioinformatics & Computational Biology
Sciences of Phytochemistry (SciPhy) is a peer-reviewed journal published by ETFLIN. SciPhy aims to offer a widely visible and highly indexed platform for scholars and intellectuals (especially the youth) to share their scientific opinions, valuable insights and scholarly works.
Start year: 14 June 2022
Language: English
Journal DOI: https://doi.org/10.58920/sciphy
Publication fee: Zero, No article processing charge
Publishing model: Gold Open Access
Free access: Immediate
Issues per year: 2 issues (biannual)
Peer review: Double blind
Review speed: 7-30 days
Acceptance to publication: 0-2 days
Reviewers per article: 2
Scope
SciPhy accepts original article, review, mini-review, technical note, case report, clinical trial, opinion/perspective, and conference proceeding that falls within the scope of the journal.
Ethnobotany and Ethnopharmacology
Field survey and documentation of traditionally important medicinal plants used by ethnic/tribal groups.
Nutraceuticals
Foods or vegetables having medicinal value. This will also include medicinal plants that are regularly consumed as vegetables.
Pharmaceutics
Development, characterization, and evaluation of herbal formulations wherein medicinal plant(s) or phytocompound(s) acts as the main active ingredient. Isolation and characterization of polymers from plants having pharmaceutical importance. Application of nanotechnology for herbal formulation development, increasing bioavailability of phytocompounds and site-specific delivery of phytocompounds.
In-silico
Application of computer-aided drug design, bioinformatics, machine learning, artificial intelligence, network pharmacology, and systems biology to evaluate the in-silico pharmacological activity (or ADMET profile) of phytocompounds (including lead identification from a phytocompound library, or identification of potential drug targets for phytocompounds). Articles reporting in-silico design and screening of synthetic analogs/semi-synthetic derivatives of phytocompounds shall be considered only if the newly designed compounds outperforms the original phytocompounds in all areas.
Clinical
Clinical studies evaluating the safety and efficacy of medicinal plants, phytocompounds and herbal formulations. Pharmacovigilance of medicinal plants shall cover drug-phytocompound interactions and adverse drug reactions due to consumption of medicinal plant products.
Method development
Development and validation of bioassay, analytical, qualitative or quantitative methods with significant utility in the field of pharmacognosy and phytochemistry.
Miscellaneous
Medicinal plant biotechnology, medicinal plant chemistry, cultivation of medicinal plants and commercialization of medicinal plant products.